期刊
BLOOD
卷 113, 期 11, 页码 2595-2604出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-10-182246
关键词
-
类别
资金
- National Institute of Dental and Craniofacial Research [R01DE017449, R21 DE017632]
- National Institutes of Health
- Department of Health and Human Services
- California Institute for Regenerative Medicine [RN1-00572]
- National Institute of Dental and Craniofacial Research
Subcutaneous transplants of bone marrow mesenchymal stem cells (BMMSCs) are capable of generating ectopic bone and organizing functional hematopoietic marrow elements in animal models. Here we report that immunocompromised mice received subcutaneous BMMSC transplants using hydroxyapatite tricalcium phosphate as a carrier suppressed age-related degeneration in multiple organs and benefited an increase in life span extension compared with control littermates. The newly organized ectopic bone/marrow system restores active hematopoiesis via the erythropoietin receptor/signal transducer and activator of transcription 5 (Stat5) pathway. Furthermore, the BMMSC recipient mice showed elevated level of Klotho and suppression of insulin-like growth factor I signaling, which may be the mechanism contributing to the alleviation of aging-like phenotypes and prolongation of life in the treated mice. This work reveals that erythropoietin receptor/Stat5 pathway contributes to BMMSC-organized ectopic hematopoiesis, which may offer a treatment paradigm of reversing age-related degeneration of multiple organs in adult immunocompromised mice. (Blood.2009;113:2595-2604)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据